Alpha Teknova, Inc. (TKNO) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the TKNO SEC filings page.
Alpha Teknova, Inc. (TKNO) reported $43.7M in revenue over the twelve months to Jun 30, 2026, up 12.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue recovered in FY2025, but cash consumption persists because gross margins and overhead still leave the business loss-making.
The gross-margin recovery to33.2% in FY2025 from19.2% in FY2024 coincided with a narrower operating loss, showing that the latest improvement reached beyond sales volume. Yet operating cash flow remained negative, so accounting improvement has not translated into cash generation; depreciation and other non-cash costs softened the gap rather than removing the underlying cash need.
Assets fell from
Capital spending fell from
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Alpha Teknova, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Alpha Teknova, Inc. held $21.3M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $8.6M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Alpha Teknova, Inc. scores 55/100 among other emerging companies.
Alpha Teknova, Inc. had 54M shares outstanding at the end of fiscal year 2025, against 53M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Alpha Teknova, Inc. scores 41/100 among other emerging companies.
Alpha Teknova, Inc. spent $2.2M on research and development in fiscal year 2025, which was 3.8% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Alpha Teknova, Inc. scores 21/100 among other emerging companies.
Alpha Teknova, Inc. reported revenue of $40.5M in fiscal year 2025, against $37.7M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Alpha Teknova, Inc. scores 50/100 among other emerging companies.
Alpha Teknova, Inc.'s operations used $8.6M of cash in fiscal year 2025, against $12.4M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Alpha Teknova, Inc. scores 73/100 among other emerging companies.
Alpha Teknova, Inc.'s cash, cash equivalents and investments came to $21.3M at the end of fiscal year 2025, against $34.8M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Alpha Teknova, Inc. scores 47/100 among other emerging companies.
Alpha Teknova, Inc. scores 5.93, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($441.3M) relative to total liabilities ($34.8M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Alpha Teknova, Inc. passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
Alpha Teknova, Inc. reported a net loss of $17.3M while operations used $8.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Alpha Teknova, Inc. reported an operating loss of $17.0M against $710K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Alpha Teknova, Inc. generated $12.2M in revenue in Q2 2026. This represents an increase of 18.5% from the same quarter a year earlier. Against the prior quarter it is up 10.0%.
Alpha Teknova, Inc.'s EBITDA was -$1.3M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 27.6% from the same quarter a year earlier. Against the prior quarter it is up 52.1%.
Alpha Teknova, Inc. reported -$3.2M in net income in Q2 2026. This represents an increase of 11.2% from the same quarter a year earlier. Against the prior quarter it is up 30.4%.
Alpha Teknova, Inc. earned -$0.06 per diluted share (EPS) in Q2 2026. This represents an increase of 14.3% from the same quarter a year earlier. Against the prior quarter it is up 25.0%.
Cash & Balance Sheet
Alpha Teknova, Inc. recorded an outflow of $596K in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 74.2% from the same quarter a year earlier. Against the prior quarter it is up 83.4%.
Alpha Teknova, Inc. held $6.0M in cash against $13.2M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Alpha Teknova, Inc.'s gross margin was 40.1% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.9 percentage points.
Alpha Teknova, Inc.'s operating margin was -23.7% in Q2 2026, reflecting core business profitability. This is up 9.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 15.1 percentage points.
Alpha Teknova, Inc.'s net profit margin was -26.0% in Q2 2026, showing the share of revenue converted to profit. This is up 8.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 15.1 percentage points.
Alpha Teknova, Inc.'s ROE was -5.1% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.0 percentage points.
Capital Allocation
Alpha Teknova, Inc. invested $554K in research and development in Q2 2026. This represents a decrease of 4.6% from the same quarter a year earlier. Against the prior quarter it is down 9.0%.
Alpha Teknova, Inc. invested $125K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 39.6% from the same quarter a year earlier. Against the prior quarter it is down 43.4%.
Not reported for Q2 2026.
TKNO Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.2M+18.5% | $11.1M+13.1% | $10.0M+7.8% | $10.5M+9.2% | $10.3M+7.0% | $9.8M+5.4% | $9.3M+17.8% | $9.6M+17.2% |
| Cost of Revenue | $7.3M+15.8% | $7.3M+7.4% | $6.7M-5.6% | $7.2M-23.6% | $6.3M-7.4% | $6.8M-4.1% | $7.1M+9.3% | $9.5M+41.6% |
| Gross Profit | $4.9M+22.6% | $3.8M+25.8% | $3.2M+52.4% | $3.2M+3462.2% | $4.0M+42.1% | $3.0M+36.1% | $2.1M+59.4% | $90K-93.9% |
| R&D Expenses | $554K-4.6% | $609K+10.3% | $522K-12.1% | $542K-13.6% | $581K-14.3% | $552K-35.8% | $594K-54.7% | $627K-55.1% |
| SG&A Expenses | $4.8M-2.4% | $5.1M-7.9% | $5.3M-1.3% | $4.6M-6.5% | $4.9M-10.1% | $5.5M-25.6% | $5.3M-11.7% | $5.0M-19.1% |
| Operating Income | -$2.9M+14.6% | -$4.3M+13.4% | -$4.6M+18.1% | -$4.0M+45.9% | -$3.4M+33.6% | -$5.0M+37.8% | -$5.6M+48.2% | -$7.4M+15.2% |
| EBITDA | -$1.3M+27.6% | -$2.7M+19.6% | -$3.0M+23.7% | -$2.4M+57.7% | -$1.8M+48.8% | -$3.4M+46.7% | -$4.0M+57.0% | -$5.7M+19.9% |
| Interest Expense | -$252K-52.7% | -$219K-52.1% | -$211K-63.6% | -$190K-34.8% | -$165K+39.3% | -$144K+0.7% | -$129K-174.6% | -$141K+82.2% |
| Income Tax | $30K+57.9% | $47K+113.6% | -$62K-63.2% | $79K+1087.5% | $19K+337.5% | $22K+164.7% | -$38K+87.5% | -$8K-188.9% |
| Net Income | -$3.2M+11.2% | -$4.6M+1.9% | -$4.8M+16.8% | -$4.3M+43.3% | -$3.6M+33.4% | -$4.6M+42.6% | -$5.7M+46.3% | -$7.6M+25.5% |
| EPS (Basic) | -$0.06+14.3% | -$0.08+11.1% | -$0.09+10.0% | -$0.08+46.7% | -$0.07+46.2% | -$0.09+55.0% | -$0.10+60.0% | -$0.15+55.9% |
| EPS (Diluted) | -$0.06+14.3% | -$0.08+11.1% | -$0.09+10.0% | -$0.08+46.7% | -$0.07+46.2% | -$0.09+55.0% | -$0.10+60.0% | -$0.15 |
| Diluted Shares (Avg) | 54M+0.3% | 54M+0.3% | N/A | 54M+3.3% | 53M+30.8% | 53M+30.9% | N/A | 52M |
TKNO Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $95.9M-13.2% | $98.7M-13.5% | $103.6M-12.8% | $107.6M-13.3% | $110.5M-4.2% | $114.0M-5.6% | $118.8M-7.6% | $124.1M-10.3% |
| Current Assets | $30.8M-19.0% | $31.7M-20.3% | $34.5M-19.3% | $36.6M-20.4% | $38.1M+7.9% | $39.7M+2.3% | $42.8M-6.3% | $45.9M-10.1% |
| Cash & Equivalents | $6.0M+83.3% | $4.3M+27.5% | $5.9M+59.4% | $3.2M-47.9% | $3.3M-82.4% | $3.4M-84.4% | $3.7M-87.0% | $6.1M-80.8% |
| Short-Term Investments | $11.4M-44.8% | $13.5M-41.1% | $15.4M-42.2% | $18.9M-26.0% | $20.7M | $22.9M | $26.7M | $25.5M |
| Inventory | $6.9M-9.2% | $6.9M+4.6% | $7.1M+3.7% | $6.9M-9.9% | $7.6M-30.7% | $6.6M-41.3% | $6.8M-41.3% | $7.7M-33.1% |
| Accounts Receivable | $5.4M+5.2% | $5.7M+1.0% | $4.6M+7.1% | $5.1M+11.5% | $5.1M+11.8% | $5.6M+23.2% | $4.3M+9.2% | $4.6M-10.8% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $33.3M-3.3% | $33.7M-4.7% | $34.8M-4.3% | $35.0M-5.0% | $34.4M-5.5% | $35.4M-5.5% | $36.4M-5.6% | $36.8M-4.9% |
| Current Liabilities | $6.9M+6.1% | $6.9M-2.1% | $7.5M-32.8% | $6.9M-28.6% | $6.5M-12.6% | $7.0M+0.1% | $11.2M+26.3% | $9.7M+16.5% |
| Non-Current Liabilities | $26.4M-5.5% | $26.8M-5.3% | $27.3M+8.4% | $28.0M+3.4% | $28.0M-3.7% | $28.3M-6.8% | $25.2M-15.2% | $27.1M-10.8% |
| Long-Term Debt | $13.2M+1.4% | $13.2M+1.4% | $13.1M+39.0% | $13.1M+20.4% | $13.0M+6.2% | $13.0M-1.4% | $9.4M-28.7% | $10.9M-17.6% |
| Total Equity | $62.6M-17.7% | $64.9M-17.4% | $68.8M-16.5% | $72.7M-16.8% | $76.1M-3.6% | $78.6M-5.7% | $82.4M-8.5% | $87.3M-12.4% |
| Retained Earnings | -$143.5M-13.2% | -$140.3M-13.9% | -$135.8M-14.6% | -$131.0M-16.2% | -$126.7M-20.4% | -$123.2M-23.3% | -$118.5M-29.1% | -$112.8M-39.1% |
Not reported in any period shown, so not listed: Goodwill.
TKNO Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$471K+77.6% | -$3.4M+18.1% | -$462K+50.6% | -$2.0M+3.8% | -$2.1M+26.0% | -$4.1M+37.4% | -$936K+67.6% | -$2.1M+53.0% |
| Depreciation & Amortization | $1.6M0.0% | $1.6M-0.3% | $1.6M-3.9% | $1.6M-5.9% | $1.6M0.0% | $1.6M-3.4% | $1.6M+2.1% | $1.7M+6.3% |
| Stock-Based Compensation | $622K-34.5% | $695K-18.4% | N/A | $850K+11.8% | $950K+14.0% | $852K-34.8% | N/A | $760K-26.6% |
| Capital Expenditures | $125K-39.6% | $221K+7.3% | $348K-38.6% | $387K+16.9% | $207K+80.0% | $206K+83.9% | $567K+81.7% | $331K-65.9% |
| Free Cash Flow | -$596K+74.2% | -$3.6M+16.9% | -$810K+46.1% | -$2.4M+1.0% | -$2.3M+21.8% | -$4.3M+35.4% | -$1.5M+53.1% | -$2.4M+55.4% |
| Investing Cash Flow | $1.9M-4.1% | $1.8M-51.9% | $3.2M+326.8% | $1.6M+106.4% | $2.0M+1863.5% | $3.8M+29315.4% | -$1.4M-1129.6% | -$25.8M-2550.1% |
| Financing Cash Flow | $224K+900.0% | -$88K-69.2% | -$37K+57.5% | $268K-98.3% | -$28K+40.4% | -$52K+84.8% | -$87K+86.0% | $15.4M+12.8% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
TKNO Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 40.1%+1.4pp | 34.2%+3.5pp | 32.5%+9.5pp | 30.7%+29.7pp | 38.7%+9.6pp | 30.7%+6.9pp | 23.0%+6.0pp | 0.9%-17.1pp |
| Operating Margin | -23.7%+9.2pp | -38.8%+11.9pp | -46.2%+14.6pp | -38.4%+39.2pp | -32.9%+20.1pp | -50.7%+35.3pp | -60.7% | -77.6% |
| Net Margin | -26.0%+8.7pp | -41.1%+6.3pp | -47.7%+14.1pp | -41.0%+38.0pp | -34.7%+21.1pp | -47.4%+39.7pp | -61.7% | -79.0% |
| Return on Equity | -5.1%-0.4pp | -7.0%-1.1pp | -6.9%0.0pp | -5.9%+2.8pp | -4.7%+2.1pp | -5.9%+3.8pp | -6.9%+4.9pp | -8.7%+1.5pp |
| Return on Assets | -3.3%-0.1pp | -4.6%-0.5pp | -4.6%+0.2pp | -4.0%+2.1pp | -3.2%+1.4pp | -4.1%+2.6pp | -4.8%+3.5pp | -6.1%+1.2pp |
| Current Ratio | 4.49-1.4x | 4.59-1.0x | 4.58+0.8x | 5.27+0.5x | 5.87+1.1x | 5.64+0.1x | 3.82-1.3x | 4.73-1.4x |
| Debt-to-Equity | 0.210.0x | 0.200.0x | 0.19+0.1x | 0.18+0.1x | 0.170.0x | 0.170.0x | 0.110.0x | 0.120.0x |
| Asset Turnover | 0.130.0x | 0.110.0x | 0.100.0x | 0.100.0x | 0.090.0x | 0.090.0x | 0.080.0x | 0.080.0x |
| FCF Margin | -4.9%+17.5pp | -32.3%+11.7pp | -8.1%+8.1pp | -22.6%+2.3pp | -22.4%+8.3pp | -44.0%+27.8pp | -16.2%+24.5pp | -25.0%+40.6pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Alpha Teknova, Inc. TKNO | FY2025 | $40.5M | -$17.3M | -42.6% | $441.3M | 48/100 |
| China SXT Pharmaceuticals, Inc. SXTC | FY2026 | $1.1M | -$6.2M | N/A | $196K | 33/100 |
| Lifecore Biomedical, Inc. LFCR | FY2025 | $128.9M | -$38.7M | -30.0% | $244.5M | 52/100 |
| Ironwood Pharmaceuticals, Inc. IRWD | FY2025 | $296.2M | $24.0M | 8.1% | $631.2M | 34/100 |
Where Alpha Teknova, Inc. Ranks
Frequently Asked Questions
What is Alpha Teknova, Inc.'s annual revenue?
Alpha Teknova, Inc. (TKNO) reported $40.5M in total revenue for fiscal year 2025. This represents a 7.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Alpha Teknova, Inc.'s revenue growing?
Alpha Teknova, Inc. (TKNO) revenue grew by 7.4% year-over-year, from $37.7M to $40.5M in fiscal year 2025.
Is Alpha Teknova, Inc. profitable?
No, Alpha Teknova, Inc. (TKNO) reported a net income of -$17.3M in fiscal year 2025, with a net profit margin of -42.6%.
What is Alpha Teknova, Inc.'s EBITDA?
Alpha Teknova, Inc. (TKNO) had EBITDA of -$10.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Alpha Teknova, Inc. have?
As of fiscal year 2025, Alpha Teknova, Inc. (TKNO) had $5.9M in cash and equivalents against $13.1M in long-term debt.
What is Alpha Teknova, Inc.'s gross margin?
Alpha Teknova, Inc. (TKNO) had a gross margin of 33.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Alpha Teknova, Inc.'s operating margin?
Alpha Teknova, Inc. (TKNO) had an operating margin of -41.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Alpha Teknova, Inc.'s net profit margin?
Alpha Teknova, Inc. (TKNO) had a net profit margin of -42.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Alpha Teknova, Inc.'s return on equity (ROE)?
Alpha Teknova, Inc. (TKNO) has a return on equity of -25.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Alpha Teknova, Inc.'s free cash flow?
Alpha Teknova, Inc. (TKNO) recorded an outflow of $9.8M in free cash flow during fiscal year 2025. This represents a 27.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Alpha Teknova, Inc.'s operating cash flow?
Alpha Teknova, Inc. (TKNO) recorded an outflow of $8.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Alpha Teknova, Inc.'s total assets?
Alpha Teknova, Inc. (TKNO) had $103.6M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Alpha Teknova, Inc.'s capital expenditures?
Alpha Teknova, Inc. (TKNO) invested $1.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Alpha Teknova, Inc. spend on research and development?
Alpha Teknova, Inc. (TKNO) invested $2.2M in research and development during fiscal year 2025.
What is Alpha Teknova, Inc.'s current ratio?
Alpha Teknova, Inc. (TKNO) had a current ratio of 4.58 as of fiscal year 2025, which is generally considered healthy.
What is Alpha Teknova, Inc.'s debt-to-equity ratio?
Alpha Teknova, Inc. (TKNO) had a debt-to-equity ratio of 0.19 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Alpha Teknova, Inc.'s return on assets (ROA)?
Alpha Teknova, Inc. (TKNO) had a return on assets of -16.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Alpha Teknova, Inc.'s P/E ratio?
Alpha Teknova, Inc. (TKNO) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $441.3M as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Alpha Teknova, Inc.'s price-to-sales ratio?
Alpha Teknova, Inc. (TKNO) trades at 10.1x sales, its market capitalization divided by revenue of $43.7M revenue, trailing 12 months to June 30, 2026. The market capitalization is $441.3M as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Alpha Teknova, Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Alpha Teknova, Inc. (TKNO) held $21.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $8.6M over that year. Dividing the one by the other, the reported balance equals about 30 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Alpha Teknova, Inc.'s Altman Z-Score?
Alpha Teknova, Inc. (TKNO) has an Altman Z-Score of 5.93, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Alpha Teknova, Inc.'s Piotroski F-Score?
Alpha Teknova, Inc. (TKNO) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Alpha Teknova, Inc.'s earnings high quality?
Alpha Teknova, Inc. (TKNO) reported a net loss of $17.3M while operations used $8.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Alpha Teknova, Inc. cover its interest payments?
Alpha Teknova, Inc. (TKNO) reported an operating loss of $17.0M against $710K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Alpha Teknova, Inc.?
Alpha Teknova, Inc. (TKNO) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.